Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

K-ras mutations in lung tumors from NNK-treated mice with lipopolysaccharide-elicited lung inflammation.

Keohavong P, Kahkonen B, Kinchington E, Yin J, Jin J, Liu X, Siegfried JM, DI YP.

Anticancer Res. 2011 Sep;31(9):2877-82.

PMID:
21868532
2.

K-ras mutations in lung tumors from A/J and A/J x TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate.

Matzinger SA, Crist KA, Stoner GD, Anderson MW, Pereira MA, Steele VE, Kelloff GJ, Lubet RA, You M.

Carcinogenesis. 1995 Oct;16(10):2487-92.

PMID:
7586156
4.
5.
6.
7.
8.

K-ras and p53 point mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced hamster lung tumors.

Oreffo VI, Lin HW, Padmanabhan R, Witschi H.

Carcinogenesis. 1993 Mar;14(3):451-5.

PMID:
8453721
11.

Comparison of pulmonary O6-methylguanine DNA adduct levels and Ki-ras activation in lung tumors from resistant and susceptible mouse strains.

Devereux TR, Belinsky SA, Maronpot RR, White CM, Hegi ME, Patel AC, Foley JF, Greenwell A, Anderson MW.

Mol Carcinog. 1993;8(3):177-85.

PMID:
8216736
12.

RNA-sequencing studies identify genes differentially regulated during inflammation-driven lung tumorigenesis and targeted by chemopreventive agents.

Qian X, Khammanivong A, Song JM, Teferi F, Upadhyaya P, Dickerson E, Kassie F.

Inflamm Res. 2015 May;64(5):343-61. doi: 10.1007/s00011-015-0815-z. Epub 2015 Mar 21.

13.

A Cyp2a polymorphism predicts susceptibility to NNK-induced lung tumorigenesis in mice.

Hollander MC, Zhou X, Maier CR, Patterson AD, Ding X, Dennis PA.

Carcinogenesis. 2011 Aug;32(8):1279-84. doi: 10.1093/carcin/bgr097. Epub 2011 May 30.

14.

Lipopolysaccharide enhances mouse lung tumorigenesis: a model for inflammation-driven lung cancer.

Melkamu T, Qian X, Upadhyaya P, O'Sullivan MG, Kassie F.

Vet Pathol. 2013 Sep;50(5):895-902. doi: 10.1177/0300985813476061. Epub 2013 Feb 4.

15.

Strain-specific spontaneous and NNK-mediated tumorigenesis in Pten+/- mice.

Hollander MC, Balogh AR, Liwanag J, Han W, Linnoila RI, Anver MR, Dennis PA.

Neoplasia. 2008 Aug;10(8):866-72.

16.

Point mutation of K-ras gene in cisplatin-induced lung tumours in A/J mice.

Hisamoto A, Kondo E, Kiura K, Okada T, Hosokawa S, Mimoto J, Takigawa N, Tabata M, Tanimoto M.

Lung Cancer. 2007 Oct;58(1):15-20. Epub 2007 Jul 2.

PMID:
17604873
17.

Chronic nicotine consumption does not influence 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis.

Murphy SE, von Weymarn LB, Schutten MM, Kassie F, Modiano JF.

Cancer Prev Res (Phila). 2011 Nov;4(11):1752-60. doi: 10.1158/1940-6207.CAPR-11-0366. Epub 2011 Oct 25.

18.

Effect of gefitinib on N-nitrosamine-4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced lung tumorigenesis in A/J mice.

Kishino D, Kiura K, Takigawa N, Katayama H, Kuyama S, Sato K, Okada T, Ohashi K, Tanimoto M.

Lung Cancer. 2009 Sep;65(3):284-9. doi: 10.1016/j.lungcan.2008.11.021. Epub 2009 Jan 18.

PMID:
19152984
19.

Occurrence of mutations in the epidermal growth factor receptor gene in X-ray-induced rat lung tumors.

Kitahashi T, Takahashi M, Yamada Y, Oghiso Y, Yokohira M, Imaida K, Tsutsumi M, Takasuka N, Sugimura T, Wakabayashi K.

Cancer Sci. 2008 Feb;99(2):241-5. doi: 10.1111/j.1349-7006.2008.00680.x.

20.

Supplemental Content

Support Center